Literature DB >> 11574500

The outcome of intracytoplasmic injection of fresh and cryopreserved ejaculated spermatozoa--a prospective randomized study.

W Kuczyński1, M Dhont, C Grygoruk, D Grochowski, S Wołczyński, M Szamatowicz.   

Abstract

BACKGROUND: The overall aim of this prospective, randomized study was to compare the reproductive potential of fresh and frozen-thawed ejaculated spermatozoa from oligoasthenoteratozoospermic patients in an intracytoplasmic sperm injection (ICSI) procedure.
METHODS: All patients consenting to participate in this study had a sperm sample frozen prior to the start of a cycle. Patients were randomized using a random number table to undergo ICSI with either fresh (group A, n = 118) or frozen-thawed (group B, n = 122) spermatozoa. All prognostic variables were equally distributed among the two groups.
RESULTS: The pregnancy rate per started cycle was 29.7% in group A and 38.5% in group B, P > 0.05. A significant difference was observed in the rate of ongoing pregnancies between group A (23.7%) and group B (35.2%), P < 0.05.
CONCLUSION: From our data we can conclude that cryopreservation of spermatozoa from men with poor sperm quality does not negatively affect fertilization and pregnancy rates after ICSI. A larger study will be needed to investigate whether the use of cryopreserved spermatozoa can be helpful in selecting the most vital spermatozoa for ICSI.

Entities:  

Mesh:

Year:  2001        PMID: 11574500     DOI: 10.1093/humrep/16.10.2109

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  13 in total

1.  Is early embryo development as observed by time-lapse microscopy dependent on whether fresh or frozen sperm was used for ICSI? A cohort study.

Authors:  Jessica Eastick; Christos Venetis; Simon Cooke; Ashleigh Storr; Daisy Susetio; Michael Chapman
Journal:  J Assist Reprod Genet       Date:  2017-04-29       Impact factor: 3.412

2.  Comparison of conventional and directional freezing for the cryopreservation of human umbilical vein endothelial cells.

Authors:  Bing Qi; Qing-Shan Ji; Guang-Hui Hou; Liu Li; Xian-Fen Cao; Jing Wu
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

3.  Sperm banking and the cancer patient.

Authors:  Daniel H Williams
Journal:  Ther Adv Urol       Date:  2010-02

4.  Management of male factor infertility: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS) : Endorsing Organization: Italian Society of Embryology, Reproduction, and Research (SIERR).

Authors:  A Ferlin; A E Calogero; C Krausz; F Lombardo; D Paoli; R Rago; C Scarica; M Simoni; C Foresta; V Rochira; E Sbardella; S Francavilla; G Corona
Journal:  J Endocrinol Invest       Date:  2022-01-24       Impact factor: 4.256

Review 5.  Fertility preservation in the male with cancer.

Authors:  Daniel H Williams
Journal:  Curr Urol Rep       Date:  2013-08       Impact factor: 3.092

Review 6.  Nonsteroidal anti-inflammatory drugs for assisted reproductive technology.

Authors:  Atunga Nyachieo; Charalampos S Siristatidis; Dennis Vaidakis
Journal:  Cochrane Database Syst Rev       Date:  2019-10-19

7.  Human Sperm Cryopreservation: Update on Techniques, Effect on DNA Integrity, and Implications for ART.

Authors:  Marlea Di Santo; Nicoletta Tarozzi; Marco Nadalini; Andrea Borini
Journal:  Adv Urol       Date:  2011-12-13

8.  Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction.

Authors:  Charalampos S Siristatidis; Eleni Sertedaki; Vasilios Karageorgiou; Dennis Vaidakis
Journal:  Cochrane Database Syst Rev       Date:  2020-08-14

9.  In cryptozoospermia or severe oligozoospermia is sperm freezing useful?

Authors:  Julien Bessonnat; Sophie Brouillet; Sarah Sintzel; Pierre Gillois; Ulrike Bergues; Caroline Boutte-Busquet; Claire Thomas-Cadi; Sylviane Hennebicq
Journal:  Basic Clin Androl       Date:  2014-10-02

Review 10.  Fertility-preserving treatment options in patients with malignant hematological diseases.

Authors:  Mert Küçük; Ali Zahit Bolaman; Irfan Yavaşoğlu; Gürhan Kadıköylü
Journal:  Turk J Haematol       Date:  2012-10-05       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.